Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 2009-08-31 |
Rod Ferguson
BRD | Director/Board Member | 69 | 2012-12-31 |
Alex Zisson
BRD | Director/Board Member | 56 | 2013-10-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.93% | +6.97% | +59.60% | +68.35% | 57.28B | ||
| -1.92% | +6.03% | +40.64% | +83.42% | 54.99B | ||
| -0.46% | -1.29% | +2.86% | +428.78% | 23.18B | ||
| -2.97% | -2.35% | -22.53% | -16.40% | 22.59B | ||
| -0.36% | +5.73% | +24.13% | -6.24% | 20.46B | ||
| -1.34% | +0.51% | +26.03% | -29.41% | 17.56B | ||
| -1.44% | +5.67% | +38.77% | +504.71% | 15.67B | ||
| -1.30% | -5.02% | +170.77% | +291.37% | 14.46B | ||
| -0.50% | -0.98% | +21.43% | +180.07% | 13.92B | ||
| Average | -1.04% | +1.28% | +40.19% | +167.18% | 26.68B | |
| Weighted average by Cap. | -0.87% | +2.10% | +39.70% | +133.49% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















